Vincenzo Mazzaferro

1. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
   2021/11/19 by Maria Reig, María Reig, Alejandro Forner +17 · 23 citations
   Medicine · #Gastric Cancer Management and Outcomes #Hepatocellular Carcinoma Treatment and Prognosis #Lung Cancer Research Studies
2. Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma
   2018/11/07 by Vincenzo Mazzaferro, Bassel F. El-Rayes, Bassel F. El‐Rayes +19 · 28 citations
   Medicine · Biochemistry, Genetics and Molecular Biology · #Cholangiocarcinoma and Gallbladder Cancer Studies #Fibroblast Growth Factor Research #Gastrointestinal Tumor Research and Treatment
3. Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference
   2020/03/26 by Neil Mehta, Prashant Bhangui, Francis Y. Yao +18 · 3 citations
   Medicine · #Hepatocellular Carcinoma Treatment and Prognosis #Liver Disease and Transplantation #Organ Transplantation Techniques and Outcomes
4. Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO
   2024/12/03 by A. Raimondi, Sara Lonardi, Sabina Murgioni +47 · 1 voice · 2 citations
   Medicine · #Cancer Immunotherapy and Biomarkers #Esophageal Cancer Research and Treatment #Gastric Cancer Management and Outcomes